Dual aVß6/aVß1 inhibitor PLN-74809 blocks multiple TGF-ß activation pathways associated with IPF

M. Decaris (South San Francisco, United States of America), J. Schaub (South San Francisco, United States of America), C. Chen (South San Francisco, United States of America), J. Cha (South San Francisco, United States of America), M. Reilly (South San Francisco, United States of America), G. Lee (South San Francisco, United States of America), M. Rexhepaj (South San Francisco, United States of America), V. Rao (South San Francisco, United States of America), P. Kotak (South San Francisco, United States of America), L. Hooi (South San Francisco, United States of America), J. Wu (South San Francisco, United States of America), S. Martin (South San Francisco, United States of America), T. Chen (South San Francisco, United States of America), M. Munoz (South San Francisco, United States of America), N. Cooper (South San Francisco, United States of America), T. Hom (South San Francisco, United States of America), K. Leftheris (South San Francisco, United States of America), P. Andre (South San Francisco, United States of America), E. Gorina (South San Francisco, United States of America), E. Lefebvre (South San Francisco, United States of America), S. Turner (South San Francisco, United States of America)

Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Session: Translational aspects of idiopathic interstitial pneumonia
Session type: Thematic Poster
Number: 1286
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Decaris (South San Francisco, United States of America), J. Schaub (South San Francisco, United States of America), C. Chen (South San Francisco, United States of America), J. Cha (South San Francisco, United States of America), M. Reilly (South San Francisco, United States of America), G. Lee (South San Francisco, United States of America), M. Rexhepaj (South San Francisco, United States of America), V. Rao (South San Francisco, United States of America), P. Kotak (South San Francisco, United States of America), L. Hooi (South San Francisco, United States of America), J. Wu (South San Francisco, United States of America), S. Martin (South San Francisco, United States of America), T. Chen (South San Francisco, United States of America), M. Munoz (South San Francisco, United States of America), N. Cooper (South San Francisco, United States of America), T. Hom (South San Francisco, United States of America), K. Leftheris (South San Francisco, United States of America), P. Andre (South San Francisco, United States of America), E. Gorina (South San Francisco, United States of America), E. Lefebvre (South San Francisco, United States of America), S. Turner (South San Francisco, United States of America). Dual aVß6/aVß1 inhibitor PLN-74809 blocks multiple TGF-ß activation pathways associated with IPF. 1286

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


TGFβ induced myofibroblast differentiation is independent of p38 activation, but requires TGFβR1 kinase activity and correlates with TGFβ-mediated SMAD signaling and TGFβ-responsive gene expression patterns in human lung fibroblasts
Source: Eur Respir J 2004; 24: Suppl. 48, 718s
Year: 2004

Inhibition of signal transduction pathways involved in inflammation
Source: Eur Respir J 2003; 22: 16S-19S
Year: 2003


Inhibition of signal transduction pathways involved in inflammation
Source: Lung Science Conference 2003 - Inflammation and Respiratory Disease
Year: 2003


Role of RhoA/Rho-kinase pathway in the regulation of eNOS activity in COPD patients
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010


Induced sputum differential gene expression implicates increased p38 signalling activity in severe asthma
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011


PP208 – SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021

Selective activation and targeting of autophagy in severe asthma.
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018




LSC - 2021 - SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



Hedgehog pathway activation is altered in COPD patients
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019


Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008


The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020




The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Differential response to stretch in different lung cells is related to differences in pi3k signalling
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009


A differential role for ceramide kinase in antigen/FcεRI mediated mast cell activation and function
Source: Eur Respir J 2006; 28: Suppl. 50, 231s
Year: 2006

Micro RNA-21 Targeting PI3K/PTEN/Akt signaling axis regulates multiple biological functions in human lung cancer
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018


Endothelin-1 activates pro-inflammatory signalling pathway via destinct p38MAPK isoforms resulting in downregulation of nuclear p27kip1
Source: Annual Congress 2009 - Airway cell biology
Year: 2009


In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis
Source: Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020
Year: 2020



The combination of PDE4 and PDE5 inhibitors reduces YAP expression in IPF
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

VIP is an endogenous inhibitor of calcineurin-NFAT signalling
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009